P/E at 63.55 vs Industry's 62.36: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Leadership

Apollo Hospitals Enterprise Ltd. trades at a P/E of 63.55, marginally above the hospital industry’s average of 62.36. This premium, though modest at approximately 1.9%, suggests that investors are willing to pay slightly more for the company’s earnings relative to its peers. Given the sector’s overall valuation, this premium may reflect confidence in the company’s market position and earnings stability. However, it also raises questions about whether the current price fully factors in potential risks or growth challenges — what is the current rating? The market cap of ₹1,15,737.30 crores places it firmly in the large-cap category, reinforcing its stature within the hospital sector.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Fluctuations

The stock’s performance over the past year has been robust, delivering a 15.21% return compared to the Sensex’s decline of 7.79%. This outperformance extends over longer horizons, with three-year returns at 81.21%, five-year returns at 149.18%, and a remarkable ten-year return of 508.09%, all significantly ahead of the Sensex’s respective 22.57%, 51.63%, and 197.90%. Such sustained gains highlight the company’s ability to generate shareholder value over time.

In contrast, the short-term performance reveals a more mixed scenario. Over the past three months, the stock has gained 6.08%, outperforming the Sensex’s 8.28% decline. The one-month return of 4.55% also contrasts with the Sensex’s 3.60% fall. However, the one-week gain of 0.37% lags behind the Sensex’s 1.48%, and the one-day gain of 0.35% is slightly below the Sensex’s 0.46%. This divergence suggests that while the medium-term momentum remains positive, recent trading has been more subdued — is this a temporary pause or a sign of shifting momentum?

Moving Average Configuration: Mixed Signals Point to Consolidation

The technical picture for Apollo Hospitals Enterprise Ltd. is nuanced. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive medium to long-term trend. However, it remains below its 5-day moving average, signalling some short-term resistance or consolidation. This configuration often suggests a recent pullback within an overall uptrend, or a pause before a potential continuation of the rally. The stock’s proximity to its 52-week high—just 2.85% away from ₹8,249.95—reinforces the idea that it is near a significant resistance level.

The recent two-day gain following a brief two-day decline further supports the notion of a tentative recovery. The interplay between short-term weakness and longer-term strength raises the question — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector has experienced varied performance recently, with some companies reporting positive results while others face headwinds. Apollo Hospitals Enterprise Ltd. stands out with its consistent outperformance over multiple timeframes. The sector’s average P/E of 62.36 reflects a generally elevated valuation environment, driven by expectations of steady demand and growth in healthcare services. Within this context, the company’s slight premium is not unusual but does highlight the importance of monitoring valuation trends closely.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd., with a Mojo Score of 75.0. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical indicators. This change invites investors to consider how the updated rating aligns with the current premium valuation and the mixed short-term momentum — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Premium Valuation with Mixed Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector, supported by strong long-term returns and a solid market capitalisation. The short-term performance and moving average configuration suggest a phase of consolidation or cautious optimism, with the stock hovering near its 52-week high but facing resistance at the very short-term level.

Investors analysing this stock must weigh the premium valuation against the mixed signals from recent price action and sector dynamics. The reassessment of the rating from Hold to a new status underscores the evolving nature of the company’s outlook — what does the current rating imply for portfolio strategy?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →